To assess the long-term efficacy and safety of conventional radiotherapy (RT) in the control of acromegaly according to recent stringent criteria of cure.A retrospective longitudinal study.Forty-seven patients with active acromegaly were treated with conventional RT between 1982 and 1994. All patients were first operated on and successively irradiated at a dose of 45-50 Gy in 25-28 fractions for persistent (n = 40) or recurrent (n = 7) disease.Long-term GH/IGF-I secretion and local tumour control were evaluated regularly, and possible side-effects were searched for systematically, especially in terms of secondary endocrine dysfunction. Biochemical cure of acromegaly was defined by glucose-suppressed plasma GH levels below 1 microg/l during an oral glucose tolerance test (OGTT) and normal age-corrected IGF-I values.The 5-, 10- and 15-year overall survival rates were 98%, 95% and 93%, respectively. Suppression of GH during OGTT was seen in 9% of patients at 2 years, 29% at 5 years, 52% at 10 years, and 77% at 15 years. Age-corrected IGF-I levels were normal in 8% of patients 2 years after RT, and this proportion increased to 23%, 42% and 61% after 5, 10 and 15 years, respectively. Normalization of GH/IGF-I mainly depended on pre-RT levels. Local tumour control was 95% at 5, 10 and 15 years after treatment. Late toxicity was mainly represented by progressive hypopituitarism, which was present in 33% of patients at baseline and increased to 57%, 78% and in 85% of patients at 5 10 and 15 years after RT, respectively.Conventional RT is effective in the long-term control of GH-secreting pituitary adenomas, although with a high prevalence of progressive hypopituitarism. At present, it remains a suitable option in acromegalic patients uncontrolled by surgery or medical therapy.

The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas / Minniti, Giuseppe; Jaffrain-Rea, Marie-Lise; Osti, Mattia; Esposito, Vincenzo; Santoro, Antonio; Solda, Francesca; Gargiulo, Patrizia; Tamburrano, Guido; Enrici, Riccardo Maurizi. - In: CLINICAL ENDOCRINOLOGY. - ISSN 0300-0664. - STAMPA. - 62:2(2005), pp. 210-216. [10.1111/j.1365-2265.2005.02199.x]

The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.

Minniti, Giuseppe;Osti, Mattia;Esposito, Vincenzo;Santoro, Antonio;Gargiulo, Patrizia;Tamburrano, Guido;Enrici, Riccardo Maurizi
2005

Abstract

To assess the long-term efficacy and safety of conventional radiotherapy (RT) in the control of acromegaly according to recent stringent criteria of cure.A retrospective longitudinal study.Forty-seven patients with active acromegaly were treated with conventional RT between 1982 and 1994. All patients were first operated on and successively irradiated at a dose of 45-50 Gy in 25-28 fractions for persistent (n = 40) or recurrent (n = 7) disease.Long-term GH/IGF-I secretion and local tumour control were evaluated regularly, and possible side-effects were searched for systematically, especially in terms of secondary endocrine dysfunction. Biochemical cure of acromegaly was defined by glucose-suppressed plasma GH levels below 1 microg/l during an oral glucose tolerance test (OGTT) and normal age-corrected IGF-I values.The 5-, 10- and 15-year overall survival rates were 98%, 95% and 93%, respectively. Suppression of GH during OGTT was seen in 9% of patients at 2 years, 29% at 5 years, 52% at 10 years, and 77% at 15 years. Age-corrected IGF-I levels were normal in 8% of patients 2 years after RT, and this proportion increased to 23%, 42% and 61% after 5, 10 and 15 years, respectively. Normalization of GH/IGF-I mainly depended on pre-RT levels. Local tumour control was 95% at 5, 10 and 15 years after treatment. Late toxicity was mainly represented by progressive hypopituitarism, which was present in 33% of patients at baseline and increased to 57%, 78% and in 85% of patients at 5 10 and 15 years after RT, respectively.Conventional RT is effective in the long-term control of GH-secreting pituitary adenomas, although with a high prevalence of progressive hypopituitarism. At present, it remains a suitable option in acromegalic patients uncontrolled by surgery or medical therapy.
2005
Acromegaly; blood/mortality/radiotherapy, Adenoma; mortality/radiotherapy/secretion, Adult, Female, Follow-Up Studies, Glucose Tolerance Test, Growth Hormone; secretion, Humans, Insulin-Like Growth Factor I; analysis, Male, Middle Aged, Pituitary Neoplasms; mortality/radiotherapy/secretion, Retrospective Studies, Survival Rate, Treatment Outcome
01 Pubblicazione su rivista::01a Articolo in rivista
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas / Minniti, Giuseppe; Jaffrain-Rea, Marie-Lise; Osti, Mattia; Esposito, Vincenzo; Santoro, Antonio; Solda, Francesca; Gargiulo, Patrizia; Tamburrano, Guido; Enrici, Riccardo Maurizi. - In: CLINICAL ENDOCRINOLOGY. - ISSN 0300-0664. - STAMPA. - 62:2(2005), pp. 210-216. [10.1111/j.1365-2265.2005.02199.x]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/455441
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 114
  • ???jsp.display-item.citation.isi??? 95
social impact